13 In 1993, The Journal of Clinical Apheresis published a paper detailing the use of TPE as either a first- or second-line therapy to be used with other modalities on disorders such as Raynauds disease, systemic lupus erythematosus, coagulation factor inhibitors, familial hypercholesterolemia, acute Guillain-Barr syndrome, chronic inflammatory demyelinating polyneuropathy, myasthenia gravis, cryoglobulinemia, Goodpastures syndrome, and thrombotic thrombocytopenic purpura
Researchers frequently use Bac Water for reconstituting lyophilized peptides and preparing sterile research solutions during in vitro laboratory applications
While BPC-157 has a strong safety record in animal studies, there are currently no long-duration, placebo-controlled human trials available to confirm its effects over months or years
Bull Exp Biol Med 2003;135:5979
Secuencia AEDG y masa molecular La molcula es el tetrapptido Ala-Glu-Asp-Gly